Ft. Crews et al., CHOLINERGIC AND SEROTONERGIC STIMULATION OF PHOSPHOINOSITIDE HYDROLYSIS IS DECREASED IN ALZHEIMERS-DISEASE, Life sciences, 55(25-26), 1994, pp. 1993-2002
Citations number
36
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
Agonist-stimulated phosphoinositide (PPI) hydrolysis is a major signal
transduction pathway in brain. These studies Investigated neurotransm
itter stimulated PPI hydrolysis in postmortem human brain. Preliminary
studies using rat brain suggested that moderate postmortem delay has
little effect on Pm hydrolysis and that human tissue might be reliably
studied for differences in receptor-PLC coupling. Studies in human br
ain membranes (frontal cortex) indicated that the time course for GTP
gamma S and carbachol/GTP gamma S-stimulated PPI hydrolysis was linear
for at least 20 min. GTP gamma S-stimulated [H-3]inositol phosphate (
InsP) formation was enhanced by carbachol (232%) and 5-Hydroxytryptami
ne (5HT-147%). SAX-HPLC separation of [3H]inositol polyphosphates indi
cated that the major isomer of inositol trisphosphate (InsP(3)) was In
s(1,4,5)P-3, the expected product of PtdIns(4,5)P-2 hydrolysis. Ca2+ i
ncreased PPI hydrolysis progressively from 100 nM through 50 mu M and
synergistically enhanced carbachol/GTP gamma S stimulation. Comparison
s of age-matched controls with Alzheimer's patients indicated that GTP
gamma S, carbachol/GTP gamma S, and 5HT/GTP gamma S-stimulation of PP
I hydrolysis is reduced approximately 50% in membranes prepared from A
lzheimer's patients. Ca2+ stimulation of PPI hydrolysis was not differ
ent between controls and Alzheimer's patients suggesting that muscarin
ic cholinergic and serotonergic receptors are uncoupled from PLC in Al
zheimer's disease. These studies indicate that there are changes in ch
olinergic and serotonergic signal transduction in Alzheimer's disease.
Further, this method can be used to study signal transduction events
in postmortem human brain.